Welcome to the e-CCO Library!

P554: Point of Care detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the biosimilar SB2: performance comparison with ELISA
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Atreya1, H. Schmitt1, S. Fischer1, M. F. Neurath1, X. Rekalde2, D. Nagore*2, A. Ametzazurra2

Created: Friday, 22 February 2019, 9:41 AM
P554: Vedolizumab Associated quality of Life and inflammatory bowel disease control Upon Entering a subcutaneous switching program (VALUE) – Results from a multi-centre UK study
Year: 2022
Source: ECCO'22
Authors: Lim, S.(1);Gros Alcade, B.(2);Lehmann, A.(3);Lindsay, J.(3);Gaya, D.(4);Caulfield, L.(4);Dhar, A.(5);Ritchie, S.(5);Limdi, J.(6);Taylor, J.(6);Raine, T.(7);Balendran, K.(7);Shuttleworth, E.(8);Kwok, J.(8);Cococcia, S.(9);Murray, C.(9);Walker, G.(10);Aldridge, R.(10);George, B.(10);Colbert, R.(4);Dawson, P.(1);Jameson, E.(1);Irving, P.(1);Sharma, E.(1);Lees, C.(2);Samaa, M.(1);
Created: Friday, 11 February 2022, 3:56 PM
P555 Frequent disease relapse after withdrawal of infliximab in IBD patients with sustained remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H. Gordon, J. Murray, F. Tailor, S.A. Goh, J.O. Lindsay

Created: Thursday, 30 January 2020, 10:12 AM
P555: Coagulation disorders in a population of patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Pinho1*, F. Pires1, D. Martins1, P. Sousa1, E. Cancela1, M. Farinha2, A. Silva1, P. Ministro1

Created: Thursday, 21 February 2019, 9:14 AM
P555: Deep remission and mucosal healing in IBD patients under immunosuppression with azathioprine and 6-mercaptopurine
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. C. Silva*1, A. P. Silva1, A. Rodrigues1, C. Fernandes1, A. Ponte1, J. Rodrigues1, M. Sousa1, A. C. Gomes1, J. Carvalho1

Created: Friday, 22 February 2019, 9:41 AM
P555: Outcomes of multiswitching from original infliximab to biosimilars in patients with inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Nascimento, C.(1);Revés, J.(1);Morão, B.(1);Frias Gomes, C.(1);Gouveia, C.(1);Palmela, C.(1);Roque Ramos, L.(1);Fidalgo, C.(1);Cravo, M.(1);Glória, L.(1);Torres, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P555: Systematic review of interventions for chronic abdominal pain management in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Norton C.1, Czuber-Dochan W.2, Artom M.2, Sweeney L.*2, Hart A.3

Created: Wednesday, 20 February 2019, 10:36 AM
P555: Systematic review with meta-analysis: The impact of cancer treatments on the disease activity of inflammatory bowel diseases
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Grimsdottir, S.(1);Attauabi, M.(1,2)*;Dahl, E.K.(1);Burisch, J.(2,3);Seidelin, J.B.(1);
Created: Friday, 14 July 2023, 11:05 AM
P555: Ustekinumab tissue and serum levels in patients with Crohn’s disease are closely correlated though not consistently associated with objective response after induction.
Year: 2022
Source: ECCO'22
Authors: Proietti, E.(1,2);Bayoumy, A.(1);Pauwels, R.(1);van der Woude, J.(1);Doukas, M.(3);Oudijk, L.(3);Peppelenbosch, M.(1);Grohmann, U.(2);Crombag, R.(4);de Vries, A.(1);Fuhler, G.(1);
Created: Friday, 11 February 2022, 3:56 PM
P556 Long-term probability of retreatment with anti-TNF therapy after discontinuation based on mucosal healing in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.M. Luque Carmona, J.M. García Ortíz, A. Nuñez Ortiz, M.D. De la Cruz Ramírez, J.M. Herrera Justiniano, E. Leo Carnerero

Created: Thursday, 30 January 2020, 10:12 AM
P556: Cyclosporine in acute severe steroid-refractory ulcerative colitis: Short-and long-term outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Hammami*, B. Hasnaoui, S. Hachicha, M. Ksiaa, H. Jaziri, N. Elleuch, A. Brahem, S. Ajmi, A. Ben Slama, A. Jmaa

Created: Thursday, 21 February 2019, 9:14 AM
P556: Female Crohn's disease patients and ulcerative colitis patients on biologic therapy are most disabled
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Spizzo P.

Created: Wednesday, 20 February 2019, 10:36 AM
P556: Safety and efficacy of ustekinumab in the treatment of Crohn's Disease: A systematic review and meta-analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: KhorshidFASGE, M.(1);Cordie, A.(2);Abd-Elsalam, S.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P556: Surgery in high-risk paediatric Crohn's Disease treated with up-front anti-TNF agents and long-standing biologic therapy
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Musto, F.(1)*;Distante, M.(2);Dei Rossi, E.(2);Calicchia, A.(3);Veraldi, S.(4);Mondi', F.(2);Tarani, F.(2);D'Arcangelo, G.(2);Aloi, M.(2);
Created: Friday, 14 July 2023, 11:05 AM
P556: The effect of multiple doses of upadacitinib 45 mg on the pharmacokinetics of cytochrome P450 substrates in healthy adult subjects
Year: 2022
Source: ECCO'22
Authors: Ibrahim, M.(1);Pangan, A.(2);Feng, T.(3);Mohamed, M.E.(1);
Created: Friday, 11 February 2022, 3:56 PM
P556: The prevalence of metabolic bone disease in patients with IBD- preliminary results from POLIBD study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Sztembis1, D. Piątek2, S. Jarmakiewicz3, P. R. Kiela4, R. Filip*5,6

Created: Friday, 22 February 2019, 9:41 AM
P557 Increased risk of anastomotic leak in Crohn’s disease patients unable to complete preoperative mechanical bowel preparation
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Iesalnieks1, F. Marek2, Z. Kala2, L. Kunovsky3

Created: Thursday, 30 January 2020, 10:12 AM
P557: Analysis of colectomy rates and advanced therapy prescribing for ulcerative colitis in Lothian; Scotland an updated population based cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jenkinson, P.(1)*;Plevris, N.(2);Gros Alcalde, B.(2);Lyons, M.(2);Derikx, L.(2);Constantine-Cooke, N.(3);Arnott, I.(2);Jones, G.(2);Lees, C.(2);
Created: Friday, 14 July 2023, 11:05 AM
P557: Cost-effectiveness of infliximab vs. surgery for severe chronic ulcerative colitis: a Markov analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Holubar1*, P. Dulai2, B. Piazik3, S. Finlayson4, B. Udeh5

Created: Thursday, 21 February 2019, 9:14 AM
P557: Long-term outcomes following laparoscopic ileocecal resection without any residual lesion for Crohn’s disease: a single-center observational study
Year: 2021
Source: ECCO'21 Virtual
Authors: Ge, X.(1);Zhou, W.(1);
Created: Wednesday, 2 June 2021, 4:12 PM